Lindsay Robertson1,2, Janet Hoek3, Anna Gilmore1, Richard Edwards 3, Anaru Waa3
1 Tobacco Control Research Group, University of Bath, UK; 2 Dept of Preventive and Social Medicine, University of Otago, NZ; 3 Dept of Public Health, University of Otago Wellington, NZ
The public will soon have the opportunity to make submissions on the long-awaited Smokefree Environments and Regulated Products (Vaping) Amendment Bill (‘the Bill’) which will regulate vaping products and alternative nicotine delivery systems. In a previous blog, ASPIRE 2025 researchers summarised the strengths and limitations of the Bill, and concluded that it contained several important measures, yet could do more to protect the health of children, young people and non-nicotine users. This blog – intended as a follow-up article to further promote discussion – summarises emerging evidence of British American Tobacco’s ambitious plans for its nicotine products, and highlights the disjunction between tobacco companies’ profit goals and public health objectives.
Prof Nick Wilson, Dr Frederieke Petrović-van der Deen, Dr Cristina Cleghorn, A/Prof Coral Gartner, Prof Tony Blakely
Our just published modelling study suggests that easier access to nicotine via vaping as a replacement for tobacco smoking, will improve the health of the NZ population. The estimated health gain is about the same as 10% per annum tobacco tax increases per year for 15 years, or a national colorectal cancer screening programme. Considering all sources of uncertainty, our study supports cautious liberalisation of nicotine-containing e-cigarettes – as NZ is doing. In this blog we discuss this new study and issues that policy-makers should consider to maximise the potential health gain – and minimise risks.
Richard Edwards, Janet Hoek, Anaru Waa – ASPIRE 2025 and University of Otago
This blog comments on the Ernst and Young (EY) report to the Ministry of Health, which evaluated tobacco excise tax increases as a strategy for achieving the Government’s Smokefree 2025 goal . The report’s recommendations, including continuing annual tax excise increases (conditional on positive impacts demonstrated in enhanced monitoring) and implementing comprehensive and multi-faceted complementary measures, are highly consistent with those made in the NZ tobacco control sector’s Achieving Smokefree Aotearoa Plan (ASAP) launched a year previously . The report strengthens the overwhelming case for implementing a Government-led, comprehensive strategy to achieve the Smokefree 2025 goal equitably for all peoples in Aotearoa.
Prof Nick Wilson, Dr Nhung Nghiem, Dr Cristina Cleghorn, Dr Frederieke Sanne van der Deen, Prof Tony Blakely
We have just published a journal article on the cost-effectiveness of NZ’s Quitline service (including its associated promotion in the mass media). The study found that this intervention package is likely to be an effective means to generate health gain, address health inequalities and save costs for the NZ health system. But in this blog we also compare the New Zealand Quitline intervention with other tobacco interventions using our just launched BODE3 Interactive League Table, and find that whilst the Quitline is a good thing to do, much more health gain is possible through other tobacco control interventions.
Professor Janet Hoek and Professor Philip Gendall
The NZ Government’s recently released Standardised Packaging Regulations contain some important advances over Australia’s legislation, but they also miss opportunities to recognise tobacco industry innovations. This blog discusses changes that establish a new benchmark and why these are important, but also examines how the regulations could have gone further and suggests measures that other countries might consider including as they develop their standardised packaging policies.